Annual profit is likely to be between $185 million and $190 million.

F&P Healthcare wins patent case against ResMed in UK Court.

Supplier Synlait also rebounds strongly.

NZ tech companies have recorded over $10 billion in revenue for the first time.

The ruling in Germany says ResMed did not infringe its patents.

NZ Refining stock falls amid pipeline repiar, while Synlait retreats from high.

Fisher & Paykel Healthcare lowered full year earnings guidance due to the strong NZ dollar

The pharmaceutical and animal health products maker posted a 4.9 per cent gain in profit.

The biggest rise and fall in net worth from this year's Rich List

Other markets don't fare so well after fall in oil price.

Orion to raise $32.9M in rights offer after posting full-year loss, sees profit in 2018.

Macquarie Group lifted its 12-month target price on F&P Healthcare by 7.3 per cent

Profit rose to a record $169m in the 12 months ended March 31, from $143m a year earlier.

COMMENT: Problems can rise in scaling start-ups into a larger sustainable company.

Business as usual is delivering results for healthcare company's chief executive.

Orion Health signed a five-year contract with Dorset County Council in England.

Orion shares have slumped for the second day in a row.

Full-year sales fell but Orion Health still expects to post a narrower loss.

A2 Milk stock falls as firm's CEO and chair sell shares.

Ebos Group's recent acquisitions helped the pharmaceutical and animal health products maker lift first-half profit 7.2 per cent.

COMMENT: Boardroom conversation is an art form for some and a learned skill for others.

US President plans a 20% tax on goods from Mexico, where F&P Healthcare manufactures medical equipment, but the Kiwi company has a work-around.

COMMENT: Governance cannot be that bad, given the growing interest in directorships from many individuals.

Wall Street set the tone for the Asian trading session

Michael Daniell has won the New Zealand Shareholders Association's 2016 Beacon Award

Orion Health narrowed its first-half loss after boosting sales of perpetual licences in North America and cutting operating costs.

Fisher & Paykel Healthcare, the medical device maker, increased first-half profit 26 per cent and widened its margins.

Kate Reid, general manager of Orion Health NZ, faints at the sight of blood.

The $37.8 million programme involves listed healthcare system software developer Orion Health, the University of Auckland, and DHBs.

New Zealand shares rose as investors reshuffled their portfolios following earnings season, with Warehouse Group and Ryman Healthcare up while Orion Health Group dropped.